IPP Bureau
Cosette Pharmaceuticals launches first generic CIPRO HC with 180 Days market exclusivity
By IPP Bureau - December 20, 2025
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
GSK’s Exdensur gains FDA nod for severe asthma with just two doses a year
By IPP Bureau - December 20, 2025
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
SandboxAQ, MapLight team up to target novel CNS therapy with AI-driven drug discovery
By IPP Bureau - December 20, 2025
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
Pfizer and Cipla forge exclusive marketing and distribution pact for key brands in India
By IPP Bureau - December 20, 2025
This marks the first partnership between Pfizer and Cipla in India
Fortis invests Rs. 840 crore for 300+ beds in Bengaluru
By IPP Bureau - December 20, 2025
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
Alembic announces USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004%
By IPP Bureau - December 20, 2025
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Lupin signs exclusive licensing pact with Neopharmed for Plasil in Philippines and Brazil
By IPP Bureau - December 19, 2025
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
Gilead’s new HIV therapy shows promising Phase 3 results
By IPP Bureau - December 19, 2025
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
Immunome’s Varegacestat shows dramatic results in Phase 3 desmoid tumor trial
By IPP Bureau - December 19, 2025
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
Takeda joins BaseLaunch to boost early-stage biotech ventures in Europe
By IPP Bureau - December 19, 2025
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
By IPP Bureau - December 19, 2025
The update promises to revolutionize laboratory workflows by optimizing resources
Ambros Therapeutics launches with $125 million to advance breakthrough therapy for rare pain disorder
By IPP Bureau - December 19, 2025
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
SABIC launches first fluorine-free polycarbonate resin to boost medical device safety
By IPP Bureau - December 19, 2025
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
ystral expands in India with new Bangalore facility, boosting team & local production
By IPP Bureau - December 19, 2025
The expansion includes a larger technical and service team and increased local procurement
